Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard Lee

Showing results (41-50 of 150) with videos related to

Pageof 15
Sort By:
Drugs in R&D|January 7, 2022
A Randomized, Double-Blind, Placebo- and Active-Controlled, Escalating Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Profiles of Subcutaneous Eflapegrastim in Healthy Japanese and Caucasian SubjectsYoomin Jeon, Nora Lee, Seungjae Baek, et al.
Reports on Progress in Physics. Physical Society (Great Britain)|March 4, 2022
Active optical metasurfaces: comprehensive review on physics, mechanisms, and prospective applicationsJingyi Yang, Sudip Gurung, Subhajit Bej, et al.
BMC Nursing|September 23, 2003
The impact of frequent injections for hematopoietic growth factor support on patients receiving chemotherapy: an observational studySusan Haithcox, Carmella R Ramnes, Howard Lee, et al.
Drug Design, Development and Therapy|September 11, 2015
Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjectsSeonghae Yoon, Donghoon Shin, Howard Lee, et al.
Clinical Pharmacology and Therapeutics|February 5, 2025
Country Contribution to Investigators of Pivotal Clinical Trials and Their Primary Publications of New Drugs Approved by the US Food and Drug Administration, 2012-2021Yoona Choi, Jung-Hyun Won, Heeju Kim, et al.
Anesthesiology Clinics|March 5, 2023
Delirium Prevention and Management in Frail Surgical PatientsKimberly F Rengel, Lindsay A Wahl, Archit Sharma, et al.
Physical Review Letters|August 29, 2014
Increased photovoltaic power output via diffractive spectrum separationGanghun Kim, Jose A Dominguez-Caballero, Howard Lee, et al.
Journal of Biomedical Informatics|January 10, 2026
Beyond Fine-Tuning: Leveraging Domain-Aware In-Context learning with large language models for clinical named entity recognitionSiun Kim, David Seung U Lee, Yujin Kim, et al.
Nanophotonics (Berlin, Germany)|December 5, 2024
Polarization-dependent photonic crystal fiber optical filters enabled by asymmetric metasurfacesIndra Ghimire, Jingyi Yang, Sudip Gurung, et al.
Clinical Pharmacology in Drug Development|April 29, 2016
A Population Pharmacokinetic Analysis of Fimasartan, a Selective Angiotensin II Receptor Antagonist, in Healthy Caucasian Subjects and Korean Patients With HypertensionHoward Lee, In-Jin Jang, Kyung-Sang Yu, et al.
Pageof 15

Showing results (41-50 of 150) with videos related to

Sort By:
Pageof 15
Drugs in R&D|January 7, 2022
A Randomized, Double-Blind, Placebo- and Active-Controlled, Escalating Single-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Profiles of Subcutaneous Eflapegrastim in Healthy Japanese and Caucasian SubjectsYoomin Jeon, Nora Lee, Seungjae Baek, et al.
Reports on Progress in Physics. Physical Society (Great Britain)|March 4, 2022
Active optical metasurfaces: comprehensive review on physics, mechanisms, and prospective applicationsJingyi Yang, Sudip Gurung, Subhajit Bej, et al.
BMC Nursing|September 23, 2003
The impact of frequent injections for hematopoietic growth factor support on patients receiving chemotherapy: an observational studySusan Haithcox, Carmella R Ramnes, Howard Lee, et al.
Drug Design, Development and Therapy|September 11, 2015
Pharmacokinetics, pharmacodynamics, and tolerability of LC350189, a novel xanthine oxidase inhibitor, in healthy subjectsSeonghae Yoon, Donghoon Shin, Howard Lee, et al.
Clinical Pharmacology and Therapeutics|February 5, 2025
Country Contribution to Investigators of Pivotal Clinical Trials and Their Primary Publications of New Drugs Approved by the US Food and Drug Administration, 2012-2021Yoona Choi, Jung-Hyun Won, Heeju Kim, et al.
Anesthesiology Clinics|March 5, 2023
Delirium Prevention and Management in Frail Surgical PatientsKimberly F Rengel, Lindsay A Wahl, Archit Sharma, et al.
Physical Review Letters|August 29, 2014
Increased photovoltaic power output via diffractive spectrum separationGanghun Kim, Jose A Dominguez-Caballero, Howard Lee, et al.
Journal of Biomedical Informatics|January 10, 2026
Beyond Fine-Tuning: Leveraging Domain-Aware In-Context learning with large language models for clinical named entity recognitionSiun Kim, David Seung U Lee, Yujin Kim, et al.
Nanophotonics (Berlin, Germany)|December 5, 2024
Polarization-dependent photonic crystal fiber optical filters enabled by asymmetric metasurfacesIndra Ghimire, Jingyi Yang, Sudip Gurung, et al.
Clinical Pharmacology in Drug Development|April 29, 2016
A Population Pharmacokinetic Analysis of Fimasartan, a Selective Angiotensin II Receptor Antagonist, in Healthy Caucasian Subjects and Korean Patients With HypertensionHoward Lee, In-Jin Jang, Kyung-Sang Yu, et al.
Pageof 15